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Abstract
Background: Dietary protein is required to attenuate the loss of muscle mass and to support recovery during a period of
hospitalization. Jejunal feeding is preferred over gastric feeding in patients who are intolerant of gastric feeding. However,
the impact of gastric vs. jejunal feeding on postprandial dietary protein digestion and absorption kinetics in vivo in humans
remains largely unexplored.
Objective:We compared the impact of gastric vs. jejunal feeding on subsequent dietary protein digestion and amino acid
(AA) absorption in vivo in healthy young men.
Methods: In a randomized crossover study design, 11 healthy young men (aged 21 6 2 y) were administered 25 g
specifically produced intrinsically L-[1-13C]phenylalanine–labeled intact casein via a nasogastric and a nasojejunal tube
placed ~30 cm distal to the ligament of Treitz. Protein was provided in a 240-mL solution administered over a 65-min period
in both feeding regimens. Blood samples were collected during the 7-h postprandial period to assess the increase in
plasma AA concentrations and dietary protein–derived plasma L-[1-13C]phenylalanine enrichment.
Results: Jejunal feeding compared with gastric feeding resulted in higher peak plasma phenylalanine, leucine, total
essential AA (EAA), and total AA concentrations (all P < 0.05). This was attributed to a more rapid release of dietary
protein–derived AAs into the circulation, as evidenced by a higher peak plasma L-[1-13C]phenylalanine enrichment
concentration (2.96 0.2 vs. 2.26 0.2 mole percent excess; P < 0.05). The total postprandial plasma AA incremental area
under the curve and time to peak did not differ after jejunal vs. gastric feeding. Plasma insulin concentrations increased to a
greater extent after jejunal feeding when compared with gastric feeding (275 6 38 vs. 178 6 38 pmol/L; P < 0.05).
Conclusions: Jejunal feeding of intact casein is followed by more rapid protein digestion and AA absorption when
compared with gastric feeding in healthy young men. The greater postprandial increase in circulating EAA concentrations
may allow a more robust increase in muscle protein synthesis rate after jejunal vs. gastric casein feeding. This trial was
registered at trialregister.nl as NTR2801. J Nutr 2015;145:2033–8.
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Introduction
Malnutrition during hospitalization is associated with greater
morbidity, mortality, length of hospital stay, and medical costs
(1). It is essential to provide adequate amounts of calories and
protein to minimize catabolism, diminish the suppression of
immune competence, and reduce the risk of septic complications
in patients (2–5). Enteral nutrition (EN)10 is preferred over
parenteral nutrition as the general route of feeding for critically
ill patients who require nutritional support therapy (6). Com-
pared with parenteral nutrition, EN is associated with a lower
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risk of infectious complications and mortality (7). Moreover, EN
allows preservation of intestinal integrity and prevents mucosal
atrophy and bacterial translocation (8, 9).
Delayed gastric emptying occurs in;50% of all mechanically
ventilated, critically ill patients and limits the administration of
EN (10). It leads to high gastric residues, higher risk of aspiration
and pneumonia, and the inability to administer required nutri-
ents. To avoid malnutrition and aspiration, patients should be fed
via an enteral tube placed in the small intestine (6, 11). Although
jejunal feeding is generally well tolerated, whether it modulates
and impairs proper dietary protein digestion and absorption is
unknown. It has been suggested that jejunal feeding requires a
predigested rather than a polymeric diet (12–14).
The fact that there are few in vivo data on the impact of
gastric vs. jejunal feeding on dietary protein digestion and
absorption is likely attributed to the obvious methodologic
limitations of in vivo human research (15). To allow in vivo
assessment of dietary protein digestion and absorption kinetics
we applied intrinsically L-[1-13C]phenylalanine–labeled protein,
which was produced by collecting milk protein from lactating
cows that had been infused with large amounts of L-[1-13C]
phenylalanine (16). We added [6,6-2H2]glucose to compare
gastric-emptying rates between regimens, because glucose is not
modulated by the gastric enzymes and acidity in the stomach.
The aim of this study was to compare the impact of gastric vs.
jejunal protein feeding on casein digestion and subsequent
amino acid (AA) absorption in healthy young men. Subjects
received (micellar) intact casein protein in this study because it is
commonly used in EN for its high essential AA (EAA) content.
Casein protein coagulates in an acidic environment such as in the
stomach, which may slow down the availability of the protein in
the digestive tract. Therefore, jejunal casein feeding may result in
more rapid digestion and subsequent absorption of dietary
protein–derived plasma AAs. Consequently, we hypothesized
that jejunal casein feeding leads to more rapid protein digestion
and AA absorption when compared with gastric feeding. In this
study we used intrinsically L-[1-13C]phenylalanine–labeled ca-
sein protein (16, 17) to assess differences in protein digestion
and AA absorption after gastric vs. jejunal casein feeding in vivo
in healthy young men.
Methods
Subjects. Twelve healthy young men (aged 216 2 y) participated in the
present study. Women were excluded because of the perceived con-
founding effect of the menstrual cycle on gastrointestinal function.
Subjects were randomly assigned to either treatment sequence: gastric-
jejunal or jejunal-gastric. Inclusion criteria were as follows: age between
18 and 45 y; a BMI (in kg/m2) between 18 and 27, which was considered
a healthy weight; not using medication; nonsmoking; no abnormalities
on general physical examination; and basic blood results within the
respective reference ranges. One subject dropped out before the start of
the study because of a vasovagal reaction on blood withdrawal. The
subjects characteristics are presented in Table 1.
This randomized crossover clinical trial was carried out at a
university-based hospital (Kennemer Gasthuis, Haarlem, Netherlands)
to evaluate the effects of 2 regimens of nutritional support on subsequent
protein digestion and AA absorption of intact casein. All subjects were
informed of the nature and possible risk of the experimental procedures
before their written informed consent was obtained. The study was
carried out after international ethical approval by the Medical Ethical
Committee of Noord-Holland, Alkmaar, Netherlands. This trial was
registered at trialregister.nl as NTR2801.
Diet and physical activity before testing. The day before the exper-
iment all of the subjects consumed a standardized diet providing 50% of
energy as carbohydrate, 16% as protein, and 34% as fat. All volunteers
were instructed to refrain from alcohol consumption, not to perform any
exhaustive physical activity, and to maintain a consistent diet 3 d before
the trial.
Experiment. According to a randomized crossover design each subject
received 240 mL fluid containing 25 g intrinsically L-[1-13C]phenylalanine–
labeled intact casein with 1 g [6,6-2H2]glucose through a nasogastric tube
(NGT) and a nasojejunal tube (NJT). A 4-wk period separated both
experimental trials. Abdominal X-ray was used to confirm that the NGT
was positioned in the stomach and theNJT;30 cmdistal to the ligament of
Treitz. Flow rate was set at 220 mL/h, resulting in a total administration
time of 65 min.
Protocol. After an overnight fast, a polyurethane catheter was placed
in a dorsal hand vein for frequent blood sampling. The administra-
tion of the fluid containing intrinsically L-[1-13C]phenylalanine–
labeled casein protein through a NGT or NJT was started directly
after basal blood sampling. Venous blood samples were collected
frequently during a 7-h postprandial period, at 15, 30, 45, 60, 75, 90,
120, 150, 180, 240, 300, 360, and 420 min. Venous blood glucose
analysis was performed immediately after collection. Blood samples
were collected in EDTA-containing tubes and serum tubes and
centrifuged at 17703 g for 12 min at 4C. Plasma and serum aliquots
were frozen and stored at –80C.
Preparation of the study fluid. Intrinsically L-[1-13C]phenylalanine–
labeled casein protein was obtained by infusing a Holstein cow with
large quantities of L-[1-13C]phenylalanine, collecting the milk, and
purifying the casein fraction as described previously (16). The L-[1-13C]
phenylalanine enrichment of the intact casein protein used was 6.1 mole
percent excess (MPE). The casein protein met all chemical and
bacteriologic specifications for human consumption. Subjects received
a volume of 240 mL through an NJT or an NGT, providing 25 g
intrinsically labeled casein protein to which 1 g [6,6-2H2]-labeled glucose
was added.
Plasma analysis. Plasma glucose concentrations were analyzed with
the HemoCue Glucose 201 DM Analyzer (HemoCue Diagnostics BV).
Insulin was analyzed by luminescence immunometric assay (Advia
Centaur; Siemens Medical Solutions Diagnostics). After precipitation of
proteins and polypeptides with perchloric acid, the plasma samples were
centrifuged, and the clear supernatant was collected. Plasma AA con-
centrations were measured byHPLC after precolumn derivatization with
o-phtaldialdehyde and fluorimetry (Nutricia Research).
For plasma phenylalanine enrichment measurements, plasma phen-
ylalanine was derivatized to its t-butyldimethyl-silyl derivative, and
its 13C enrichment was determined by electron impact ionization gas
chromatography–mass spectrometry (model 6890N GC/5973N MSD;
Agilent) by using selected ion monitoring of masses 336 and 337 for
unlabeled and [1-13C]-labeled phenylalanine, respectively (18). We
applied standard regression curves in all isotopic enrichment analyses
to assess the linearity of the mass spectrometer and to control for the loss
of tracer. Enrichments were corrected for the presence of [1-13C]
phenylalanine isotopes in baseline samples (19). After derivatization of
the plasma samples, plasma [6,6-2H2]glucose enrichment was measured
TABLE 1 Baseline characteristics of study participants1
Value
Age, y 21.7 6 2.1
Height, m 1.87 6 0.06
Weight, kg 80.2 6 9.3
BMI, kg/m2 23.0 6 1.9
Basal plasma glucose, mmol/L 5.6 6 0.4
Basal plasma insulin, pmol/L 63 6 24
HOMA-IR 2.3 6 0.9
1 Values are means 6 SDs; n = 11.














by electron impact ionization gas chromatography–mass spectrometry
(Finnigan INCOS-XL; Finnigan Mat).
Statistical analysis. Baseline characteristics are expressed as means 6
SDs. P values are based on Students t test for independent samples.
Efficacy parameters P value are based on repeated measures mixed
model ANOVA with fixed factors: treatment, period, sequence, and
random-factor subject. The P value of ‘‘within time analysis’’ to compare
differences between treatments over time is based on repeated measures
mixed model ANOVA with fixed factors: treatment, period, sequence,
time and time  treatment interaction, and random-factor subject. For
variables with ordered or ordinal categories, the Wilcoxons signed rank
test was used and binomial variables were analyzed by usingMcNemars
test. Significance was set at P < 0.05. All calculations were performed by
Nutricia Research Utrecht with the use of SAS (SAS Enterprise Guide 4.3
or higher) for Windows (SAS Institute).
Results
Plasma glucose and insulin. Plasma glucose concentrations
did not change significantly during casein administration and
averaged 5.3 6 0.1 mmol/L after gastric feeding and 5.2 6
0.1 mmol/L after jejunal feeding (Figure 1A). After the onset of
casein administration, plasma insulin concentrations showed a
rapid but short-lived increase in both feeding regimens (Figure
1B). Peak plasma insulin concentrations were higher after
jejunal (275 6 38 pmol/L) than after gastric (178 6 38 pmol/L)
feeding (P < 0.05). The incremental AUC (iAUC) was also
significantly higher after jejunal (9880 6 1690 pmol/L  7 h)
than after gastric (61806 1760 pmol/L  7h) feeding (P < 0.05).
Within-time analysis showed a significantly higher concentra-
tion at 45, 60, and 75 min after jejunal feeding than after gastric
feeding (Figure 1B).
Plasma AAs. Plasma phenylalanine, leucine, and the sum of all
EAA and AA concentrations over time are shown in Figure 2.
Baseline and peak values, time to peak, and the iAUC of plasma
phenylalanine, leucine, and the sum of all EAA and AA
concentrations are presented in Table 2.
Peak plasma phenylalanine concentrations were significantly
higher after jejunal feeding than after gastric feeding (Table 2).
Within-time analysis showed significantly higher concentrations
FIGURE 1 Plasma glucose (A) and insulin (B) concentrations after
either gastric or jejunal casein protein feeding in healthy young men.
Values are means6 SEMs, n = 11. Data were analyzed with repeated-
measures mixed-model ANOVA. *Different from jejunal feeding, P ,
0.05.
FIGURE 2 Plasma phenylalanine (A), leucine (B), and the sum of all
EAA (C) and AA (D) concentrations after either gastric or jejunal casein
protein feeding in healthy young men. Values are means 6 SEMs, n =
11. Data were analyzed with repeated-measures mixed-model
ANOVA. *Different from jejunal feeding, P , 0.05. AA, amino acid;
EAA, essential amino acid.














at 45, 60, 75, and 90 min after jejunal vs. gastric feeding (Figure
2A). Peak plasma leucine concentrations were significantly
higher after jejunal feeding than after gastric feeding (Table 2).
Within-time analysis showed significantly higher concentrations
at 45, 60, 75, and 90 min after jejunal vs. gastric feeding (Figure
2B). Peak plasma EAA concentrations were significantly higher
after jejunal feeding than after gastric feeding (Table 2). Within-
time analysis showed significantly higher concentrations at 45,
60, 75, and 90 min after jejunal vs. gastric feeding (Figure 2C).
Peak plasma AA concentrations were significantly higher after
jejunal feeding than after gastric feeding (Table 2). Within-time
analysis showed significantly higher concentrations at 45, 60,
75, and 90 min after jejunal vs. gastric feeding (Figure 2D).
Plasma tracer enrichments. Plasma L-[1-13C]phenylalanine
enrichments increased immediately after casein administration
in both groups (Figure 3). Peak plasma L-[1-13C]phenylalanine
enrichments were significantly higher after jejunal feeding (2.96
0.2 MPE) than after gastric feeding (2.2 6 0.2 MPE) (P < 0.05).
Time to peak and the iAUC did not differ significantly between
groups. Within-time analysis showed significantly higher con-
centrations at 45, 60, 75, and 90 min after jejunal feeding than
after gastric feeding, although at 240, 300, and 360 min con-
centrations were significantly higher after gastric feeding than
after jejunal feeding.
Plasma [6,6-2H2]glucose enrichment increased immediately
after casein administration in both groups (Figure 3). The
increase in [6,6-2H2]glucose enrichment did not differ signifi-
cantly between feeding regimens. Time to peak, peak value, and
the iAUC of plasma [6,6-2H2]glucose enrichments did not differ
significantly between regimens.
Safety and tolerance. A data safety monitoring board was
installed before the first subject was enrolled to ensure an
ongoing evaluation of the serious adverse events (AEs) that
might occur during the study. Data on tolerance of the study
product were collected every 4 h with a visual analog scale. No
serious AEs were reported. A total of 3 AEs were possibly related
to the administration of intact casein, of which 1 was reported
with gastric feeding (occurring in 1 subject: nausea) and 2 with
jejunal feeding (occurring in 2 subjects: 1 with nausea, 1 with
diarrhea). The number of AEs was not significantly different
between groups. Blood safety variables all remained within the
respective reference ranges, and no clinically relevant changes in
liver and kidney function were observed (data not shown).
Discussion
In the present study, we compared the impact of gastric vs.
jejunal casein protein feeding on protein digestion and subse-
quent AA absorption in healthy young men. Jejunal feeding of
intact micellar casein protein was followed by a more rapid
release of dietary protein–derived AAs in plasma when com-
pared with gastric feeding. This implies that jejunal casein
feeding is followed by more rapid protein digestion and AA
absorption than with gastric feeding.
The apparent differences in dietary protein digestion and AA
absorption after gastric and jejunal feeding may be attributed to
various factors, ranging from gastric emptying to protein
hydrolysis and mucosal AA absorption (21). In the present
study, we also added [6,6-2H2]glucose to the solutions to
compare the appearance rates of both exogenous glucose and
protein-derived phenylalanine after gastric vs. jejunal feeding. It
is evident from the data presented in Figure 3B that there is an
TABLE 2 Baseline and peak values, time to peak, and iAUC of
phenylalanine, leucine, and all EAAs and AAs after gastric or
jejunal casein protein feeding in healthy young men1
Gastric feeding Jejunal feeding
Phenylalanine
Baseline, μmol/L 63 6 3 62 6 3
Peak value, μmol/L 100 6 6 124 6 6*
Time to peak, min 90 6 17 74 6 17
iAUC, mmol/L  7 h 3 6 1 4 6 1
Leucine
Baseline, μmol/L 146 6 13 147 6 13
Peak value, μmol/L 313 6 22 420 6 22*
Time to peak, min 90 6 17 77 6 17
iAUC, mmol/L  7 h 16 6 2 19 6 2
Sum of all EAAs
Baseline, μmol/L 1040 6 54.0 1020 6 54.0
Peak value, μmol/L 1770 6 93.0 2210 6 93.0*
Time to peak, min 92 6 17 79 6 17
iAUC, mmol/L  7 h 81 6 9 88 6 8
Sum of all AAs
Baseline, μmol/L 2580 6 92.0 2480 6 92.0
Peak value, μmol/L 3720 6 150 4300 6 150*
Time to peak, min 98 6 17 78 6 17
iAUC, mmol/L  7 h 109 6 13 126 6 12
1 Values are means 6 SEMs, n = 11. Data were analyzed with repeated-measures
mixed-model ANOVA. *Different from gastric feeding, P , 0.05. AA, amino acid; EAA,
essential amino acid; iAUC, incremental AUC.
FIGURE 3 Plasma L-[1-13C]phenylalanine (A) and [6,6-2H2]glucose
(B) enrichment after either gastric or jejunal casein protein feeding in
healthy young men. Values are means 6 SEMs, n = 11. Data were
analyzed with repeated-measures mixed-model ANOVA. *Different
from jejunal feeding, P , 0.05. MPE, mole percent excess.














earlier increase in [6,6-2H2]glucose appearance after jejunal
feeding than after gastric feeding. This is not surprising because
glucose does not need to travel from the stomach first after
jejunal feeding. As was evident from the SDs and the variance in
the measurements between subjects, there was much less
variation in the postprandial increase in plasma [6,6-2H2]
glucose when compared with L-[1-13C]phenylalanine enrich-
ments after jejunal vs. gastric feeding. The apparent differences
in micellar casein protein digestion and AA absorption rate after
gastric vs. jejunal feeding are likely attributable to the coagu-
lation of micellar casein in the acidic environment of the
stomach (20). The clotting of the casein in the stomach
attenuates gastric emptying and changes in micellar structure
render the casein less accessible to luminal digestion, both of
which result in slower mucosal AA absorption after gastric vs.
jejunal feeding. These findings indicate that predigestion of
micellar casein by gastric acid is not required and may even
reduce the capacity to degrade intact casein into peptides and
AAs. Our results indicate that jejunal feeding with micellar
casein allows more rapid protein digestion and AA absorption
than does gastric feeding.
Postprandial protein kinetics are affected by the rate of
dietary protein digestion and subsequent absorption of dietary
protein–derived AAs. Dietary proteins are commonly classified
as ‘‘fast’’ or ‘‘slow,’’ because it is well recognized that their
structure affects their rate of digestion and absorption, which
strongly modulates the postprandial hormonal and metabolic
response as well as postprandial protein accretion (22). Intact
casein is generally classified as a slowly digestible protein and is
commonly used in EN because of its high EAA content (23). As
shown in Figure 3, we observed a more rapid and greater
increase in L-[1-13C]phenylalanine enrichment after jejunal vs.
gastric feeding. In line with this finding, we observed a more
rapid increase in circulating plasma phenylalanine, leucine, total
EAA, and total AA concentrations after jejunal casein feeding
when compared with gastric casein feeding (Figure 2). This
suggests that jejunal casein feeding results in more rapid protein
digestion and AA absorption when compared with gastric
feeding, turning the ‘‘slow’’ casein into a ‘‘fast’’ casein protein.
In the present study we used specifically produced intrinsi-
cally L-[1-13C]phenylalanine–labeled casein protein to allow an
appropriate comparison of in vivo dietary protein digestion and
subsequent AA absorption between both feeding regimens. The
ingestion of more rapidly digestible protein results in a more
rapid increase in circulating AAs and greater postprandial
plasma AA availability, thereby increasing postprandial muscle
protein accretion (22, 24, 25). Because we did not apply
continuous intravenous infusions with a secondary phenylalanine
tracer, we cannot quantify the absolute amount of dietary
protein–derived AAs that were released in the circulation after
protein feeding. However, because we observed no differences in
the time to peak or iAUC of phenyalanine between trials, there is
no indication that there were substantial differences in the
overall postprandial release of dietary protein–derived AAs in
the circulation between feeding groups during the evaluated
postprandial period. Previously, Koopman et al. (26) compared
dietary protein digestion and absorption kinetics after the
ingestion of a single bolus of intact and hydrolyzed casein and
found that the ingestion of casein hydrolysate resulted in more
rapid protein digestion and AA absorption from the gut,
augmented postprandial plasma AA availability, and tended to
increase the incorporation rate of dietary protein–derived AAs
into de novo skeletal muscle protein. The jejunal feeding of the
casein seems to mimic the response we previously observed after
the ingestion of hydrolyzed casein as opposed to intact (micellar)
casein. The greater postprandial increase in circulating EAA
concentrations, and plasma leucine concentrations in particular
(27, 28), may allow a more robust increase in muscle protein
synthesis rate after jejunal vs. gastric casein feeding, which may
be particularly relevant in conditions of anabolic resistance (29).
The development of insulin resistance during hospitalization
is an unwanted phenomenon, because it may lead to more
infectious complications and a prolonged length of hospital stay
(30). Elevated postprandial insulin concentrations have been
shown to inhibit proteolysis, stimulate AA uptake, and/or
augment muscle protein synthesis (31, 32). Increases in plasma
insulin concentrations were observed after the intravenous
infusion of free AAs (33). However, the insulinotropic properties
of protein when given either via gastric or jejunal routes have not
been investigated previously. As shown in Figure 1, we observed
a greater increase in insulin concentrations after jejunal when
compared with gastric feeding, implying that a more rapid
release of AAs in the circulation stimulates endogenous insulin
release. In accordance, it has been well established that a more
rapid increase in circulating plasma AA concentrations stimu-
lates endogenous insulin release, thereby attenuating postprandial
blood glucose excursions (34).
The current study is the first, to our knowledge, to compare in
vivo dietary protein digestion and absorption kinetics after
jejunal vs. gastric casein feeding in healthy young men. We
conclude that jejunal casein protein feeding allows a more rapid
dietary protein digestion and subsequent AA absorption when
compared with gastric feeding. The present findings show that
feeding strategy can have a distinct impact on dietary protein
digestion and AA absorption kinetics and, as such, may also
modulate postprandial muscle protein accretion.
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